Enhancement of erythrocyte oxygen transport function after hydrothermic storage under the action of human cord blood low-molecular fraction and the Actovegin drug
DOI:
https://doi.org/10.15407/dopovidi2020.11.085Keywords:
Actovegin, cord blood, erythrocytes, hypothermia, oxygen transport functionAbstract
We study the effect of a low-molecular fraction (below 10 kDa) derived from human cord blood and Actovegin on the content of various forms of hemoglobin in erythrocytes stored under hypothermia (2-4 ºС) for 21 days. During the long-term storage of erythrocytes, there is known to be a change in the hemoglobin forms ratio toward the decrease of the relative content of oxyhemoglobin and an increase of deoxy- and methemoglobin. As a result, the affinity of hemoglobin for oxygen reduces. The incubation of erythrocytes in a rehabilitation medium with each of the studied low-molecular drugs was found to be crucial to increase the content of oxyhemoglobin and to reduce the amounts of deoxy- and methemoglobin relative to the control. As a result, there was a rise in the oxygenation coefficient, reflecting the oxygen saturation of hemoglobin, up to the level characteristic of freshly isolated erythrocytes. The data obtained show that the human cord blood low-molecular fraction and the Actovegin normalize the ratio of hemoglobin forms in hypothermically stored erythrocytes, but the use of the Actovegin drug is more effective.
Downloads
References
Silini, A. R., Cargnoni, A., Magatti, M., Pianta, S. & Parolini, O. (2015). The long path of human placenta, and its derivatives, in regenerative medicine. Front. Bioeng. Biotechnol., No. 3, 162, https://doi.org/10.3389/fbioe.2015.00162
Emara, A. K., Anis, H. & Piuzzi, N. S. (2020). Human placental extract: the feasibility of translation from basic science into clinical practice. Ann. Transl. Med., 8, No. 5, 156. https://doi.org/10.21037/atm.2020.01.50
Gulevsky, A.K., Moiseyeva, N.N. & Gorina, O.L. (2011). Influence of low-molecular (below 5 kDa) fraction from cord blood and actovegin on phagocytic activity of frozen-thawed neutrophils. CryoLetters, 32, No. 2, pp.131-140. https://doi.org/10.1155/2011/214124
Shakouri-Motlagh, A., Khanabdali, R., Heath, D. E & Kalionis, B. (2017). The application of decellularized human term fetal membranes in tissue engineering and regenerative medicine (TERM). Placenta, 59, pp. 124-130. https://doi.org/10.1016/j.placenta.2017.07.002
Harrell, C. R., Jankovic, M. G., Fellabaum, C., Volarevic, A., Djonov, V., Arsenijevic, A. & Volarevic, V. (2019). Molecular mechanisms responsible for anti-inflammatory and immunosuppressive effects of mesenchymal stem cell-derived factors. Adv. Exp. Med. Biol., 1084, pp. 187-206. https://doi.org/10.1007/5584_2018_306
Cai, Y., Li, J., Jia, C., He, Y. & Deng, C. (2020). Therapeutic applications of adipose cell-free derivatives: a review. Stem Cell Res Ther., 11, No. 1, 312. https://doi.org/10.1186/s13287-020-01831-3
Kumar, L. P., Kandoi, S., Misra, R., Vijayalakshmi, S., Rajagopal, K. & Vermа, R. S. (2019). The mesenchymal stem cell secretome: a new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev., 46, pp. 1-9. https://doi.org/10.1016/j.cytogfr.2019.04.002
Gulevsky, А. K., Akhatova, Yu. S., Sysoev, А. А. & Sysoeva, I. V. (2015). Energy metabolism of packed white cells after cryopreservation and rehabilitation in a medium containing a cord blood low-molecular fraction. Biotechnologia Acta, 8, No. 6, pp. 63-70 (in Ukranian). https://doi.org/10.15407/biotech8.06.063
Cavezzi, A., Troiani, E. & Corrao, S. (2020). COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract., 10, No. 2, 1271. https://doi.org/10.4081/cp.2020.1271
Liu, W. & Li, H. (2020). COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv, https://doi.org/10.26434/chemrxiv.11938173.v11938178
Sotoudeh, E. & Sotoudeh, H. (2020). A hypothesis about the role of fetal hemoglobin in COVID-19. Med. Hypotheses, 144, 109994. https://doi.org/10.1016/j.mehy.2020.109994
Pat. 69652 Ukraine, IPC A 61 K 35/14. The method of obtaining low molecular weight fraction from cord blood of cattle. Gulevsky, О.К., Moіseeva, N.M., Abakumova, O.S., Schenyavsky, I.Y., Nikolchenko, A.Yu. & Gorina, O.L., Publ. 10.05.2012 (in Ukranian).
Stus, L. N., Rozanova, E.D. (1992). The oscillation of hemoglobin forms during blood storage. Biophysics. 37, No. 2, pp. 387-388 (in Russian).
Buchmayer, F., Pleiner, J., Elmlinger, M. W., Lauer, G., Nell, G. & Sitte, H. H. (2011). Actovegin®: a biological drug for more than 5 decades. Wien Med Wochenschr., 161, No. 3-4, pp. 80-88. https://doi.org/10.1007/s10354-011-0865-y
Zharkova, E. E. & Gulevsky, A. K. (2018). Effect of cryohemolyzed human cord blood-derived low molecular fraction on recovery of morphological properties and metabolism of ATP and 2,3-DPG of human donor blood erythrocytes under hypothermic storage. Probl. Cryobiol. Cryomed., 28, No. 2, pp. 157. https://doi.org/10.15407/cryo28.02.157
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Reports of the National Academy of Sciences of Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
